SCHEMBL4899482

SCHEMBL4899482

Cc1ccc(S(=O)(=O)NCCSc2ncc(C(F)(F)F)cc2Cl)cc1C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.52
MEN1 O00255 3/20 0.52
ALDH1A1 P00352 8/20 0.48
LMNA P02545 7/20 0.48
NPSR1 Q6W5P4 4/20 0.48
GAA P10253 4/20 0.48
MAPT P10636 3/20 0.48
HTT P42858 3/20 0.48
HPGD P15428 2/20 0.45
POLB P06746 1/20 0.45
USP2 O75604 1/20 0.45
PKM P14618 2/20 0.45
KDM4E B2RXH2 1/20 0.45
L3MBTL1 Q9Y468 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4904097 0.92 KMT2A (0.51) KMT2AMEN1ALDH1A1LMNANPSR1
SCHEMBL4905173 0.90 ALDH1A1 (0.47) KMT2AMEN1ALDH1A1LMNANPSR1
SCHEMBL4906535 0.84 ALDH1A1 (0.51) KMT2AMEN1ALDH1A1LMNAMAPT
SCHEMBL4895719 0.83 ALDH1A1 (0.48) KMT2AMEN1ALDH1A1LMNANPSR1
SCHEMBL4899856 0.81 LMNA (0.53) KMT2AMEN1ALDH1A1LMNAGAA
SCHEMBL4907291 0.80 LMNA (0.50) KMT2AMEN1ALDH1A1LMNAMAPT
SCHEMBL4899491 0.77 KMT2A (0.53) KMT2AMEN1ALDH1A1LMNANPSR1
SCHEMBL4906838 0.76 LMNA (0.48) KMT2AMEN1ALDH1A1LMNAGAA
SCHEMBL4900537 0.76 ALDH1A1 (0.50) KMT2AMEN1ALDH1A1LMNAGAA
SCHEMBL4905465 0.74 ALDH1A1 (0.48) KMT2AMEN1ALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD KMT2A 3602/4885MEN1 4859/4885ALDH1A1 2664/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD KMT2A 3530/4885MEN1 4855/4885ALDH1A1 2956/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD KMT2A 3530/4885MEN1 4855/4885ALDH1A1 2956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.